PTC Therapeutics (NASDAQ:PTCT) Price Target Raised to $45.00
PTC Therapeutics (NASDAQ:PTCT – Get Free Report) had its price target hoisted by analysts at Morgan Stanley from $32.00 to $45.00 in a note issued to investors on Friday, Benzinga reports. The firm currently has an “equal weight” rating on the biopharmaceutical company’s stock. Morgan Stanley’s price target indicates a potential upside of 15.33% from […]
11 Oct 16:56 · The Markets Daily